Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective lowered by Royal Bank of Canada from $136.00 to $133.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price would indicate a potential upside of […]

BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its price target dropped by equities researchers at Royal Bank of Canada from $85.00 to $80.00 in a research note issued on Friday, Benzinga reports. The firm presently has a “sector perform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price objective would indicate a […]

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target upped by equities research analysts at Royal Bank of Canada from $74.00 to $75.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target suggests a potential […]

Bank of America (NYSE:BAC) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday. A number of other research analysts have also weighed in on BAC. Deutsche Bank Aktiengesellschaft raised shares of Bank of America from a “hold” rating to a “buy” […]

agilon health (NYSE:AGL – Get Free Report) was downgraded by investment analysts at Bank of America from a “buy” rating to an “underperform” rating in a report issued on Wednesday, Marketbeat.com reports. They presently have a $3.00 price objective on the stock. Bank of America‘s price objective would suggest a potential downside of 5.21% from […]

Fiserv (NYSE:FI – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Royal Bank of Canada in a note issued to investors on Wednesday, Benzinga reports. They presently have a $183.00 price target on the business services provider’s stock. Royal Bank of Canada’s price target indicates a potential downside of 0.20% from […]